GONG XIFACAI GIFT CHOCOLATES, 238 grams, UPC 6 934169 900335 --- MANUFACTURER: JIANGXI GOLDEN EAGLE FOOD CO. LTD, ADD: NO. 188, YONGQIANG...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2423-2014.
The product contained undeclared peanuts and milk based on sampling and analysis by New York State Department of Agriculture & Markets.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2423-2014.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Domega Ny International Co Ltd or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2423-2014.
Domega NY International Co Ltd
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Domega Ny International Co Ltd Recall FAQ
Domega Ny International Co Ltd is the subject of a snacks & candy safety report: GONG XIFACAI GIFT CHOCOLATES, 238 grams, UPC 6 934169 900335 --- MANUFACTURER: JIANGXI GOLDEN EAGLE FOOD CO. LTD, ADD: NO. 188, YONGQIANG.... The notice was published on June 17, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 189 units are potentially affected.